A top executive for Pfizer suggested to investors last week that pricing for its COVID-19 vaccine could increase post-pandemic. The suggestion raises questions about whether a drug, developed at the … [+6425 chars] Post Views: 10 Share this...FacebookPinterestTwitterLinkedin 2021-03-17